Shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Get Free Report) have earned a consensus rating of "Moderate Buy" from the eight analysts that are presently covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $126.50.
A number of equities analysts have issued reports on the stock. Stifel Nicolaus cut their target price on shares of Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating on the stock in a report on Thursday, April 17th. Susquehanna raised their price target on shares of Silicon Laboratories from $100.00 to $110.00 and gave the company a "neutral" rating in a research note on Wednesday, May 14th. Wall Street Zen upgraded Silicon Laboratories from a "sell" rating to a "hold" rating in a research report on Wednesday, May 14th. Needham & Company LLC reissued a "buy" rating and issued a $150.00 price objective on shares of Silicon Laboratories in a report on Wednesday, May 14th. Finally, Benchmark reaffirmed a "buy" rating and set a $160.00 target price on shares of Silicon Laboratories in a research note on Wednesday, May 14th.
Read Our Latest Stock Report on SLAB
Silicon Laboratories Price Performance
Shares of SLAB stock traded down $1.32 on Wednesday, hitting $121.43. 265,583 shares of the stock traded hands, compared to its average volume of 337,770. The company's fifty day moving average is $108.77 and its 200 day moving average is $121.84. Silicon Laboratories has a 1-year low of $82.82 and a 1-year high of $160.00. The company has a market capitalization of $3.96 billion, a PE ratio of -20.44 and a beta of 1.36.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its earnings results on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $0.01. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The company had revenue of $177.71 million for the quarter, compared to analysts' expectations of $177.48 million. During the same period in the prior year, the company earned ($0.92) earnings per share. The firm's revenue was up 67.0% compared to the same quarter last year. As a group, equities research analysts expect that Silicon Laboratories will post -0.97 EPS for the current year.
Insider Activity
In other Silicon Laboratories news, Director Christy Wyatt sold 546 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $104.45, for a total transaction of $57,029.70. Following the completion of the transaction, the director now directly owns 8,492 shares of the company's stock, valued at approximately $886,989.40. This trade represents a 6.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Robert J. Conrad sold 1,172 shares of Silicon Laboratories stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $130.00, for a total value of $152,360.00. Following the transaction, the senior vice president now owns 15,972 shares in the company, valued at approximately $2,076,360. This trade represents a 6.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,626 shares of company stock worth $1,509,319 over the last three months. Corporate insiders own 1.60% of the company's stock.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the company. Quarry LP bought a new stake in Silicon Laboratories in the first quarter worth about $25,000. Jones Financial Companies Lllp grew its stake in shares of Silicon Laboratories by 44.5% in the 4th quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 69 shares during the last quarter. Skandinaviska Enskilda Banken AB publ bought a new stake in shares of Silicon Laboratories in the 1st quarter worth approximately $34,000. UMB Bank n.a. raised its holdings in shares of Silicon Laboratories by 111.3% in the 1st quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company's stock worth $38,000 after purchasing an additional 177 shares in the last quarter. Finally, Parallel Advisors LLC lifted its stake in Silicon Laboratories by 143.7% during the first quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company's stock valued at $52,000 after purchasing an additional 273 shares during the last quarter.
About Silicon Laboratories
(
Get Free ReportSilicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
See Also

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.